Arbutus Biopharma (ABUS) Stock
Arbutus Biopharma (ABUS) closed at $4.09 on Nov 13, 2026; its Tenet Score is 49 of 100 against 409 Healthcare peers.
Key stats
- Previous close
- $4.09
- Nov 13, 2026
- Market cap
- $627.0M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 2.9×
- price ÷ trailing EPS, Nov 13, 2026 close
- Dividend yield
- 0.00%
- reinvests all
- 52-week range
- 3.50 – 5.45
- low → high
- Tenet Score
- 49/100
- Mixed · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Arbutus Biopharma Corp scores 49/100. Mixed. Growth is the soft spot, trading at 3× earnings versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ~ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Munger Compounders
- ✓ Magic Formula
- ✕ Graham Defensive
- ✕ Quality Compounder
No dividend. Cash stays in the business.
13F flows & insider trades land here.
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcu…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| DBV TechnologiesDBVT | 32 | $692.6M |
| Universe Pharmaceuticals INCUPC | 64 | $688.4M |
| Cullinan Therapeutics IncCGEM | 54 | $667.4M |
| Olema Oncology Inc.OLMA | 55 | $662.3M |
| Immix Biopharma IncIMMX | 69 | $657.1M |
| Geron Corp.GERN | 56 | $623.0M |
| Wave Life Sciences Inc.WVE | 54 | $617.3M |
| Pacific Biosciences of California, IncPACB | 40 | $613.3M |
| Climb Bio Inc.CLYM | 62 | $608.5M |
| Sana Biotechnology IncSANA | 34 | $605.3M |
Common questions
What sector and industry is Arbutus Biopharma in?
Arbutus Biopharma is in the Healthcare sector and the Drugs industry.
What is Arbutus Biopharma's Tenet Score?
Arbutus Biopharma's Tenet Score is 49 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




